We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$145M
2
TSM icon
TSMC
TSM
+$120M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$37.4M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.96M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$322M
2
MSFT icon
Microsoft
MSFT
+$269M
3
AMZN icon
Amazon
AMZN
+$128M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$107M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$80.6M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YCBD icon
5251
cbdMD
YCBD
$6.19M
$3K ﹤0.01%
42
+4
+11% +$403
YMAB
5252
DELISTED
Y-mAbs Therapeutics
YMAB
$3K ﹤0.01%
576
-1,008
-64% -$7.32K
ZIMV
5253
DELISTED
ZimVie
ZIMV
$3K ﹤0.01%
345
-4,437
-93% -$38.8K
TRUG icon
5254
TruGolf
TRUG
$980K
$3K ﹤0.01%
+1
New +$5.08K
ORKA
5255
Oruka Therapeutics
ORKA
$7.19B
$3K ﹤0.01%
123
+79
+180% +$2.02K
NIXX
5256
Nixxy Inc
NIXX
$16.6M
$3K ﹤0.01%
509
+50
+11% +$435
CYCU
5257
Cycurion Inc
CYCU
$7.28M
$3K ﹤0.01%
7
+1
+17% +$302
ASBP
5258
Aspire Biopharma
ASBP
$9.86M
– –
0
– –
RDGT
5259
Ridgetech Inc
RDGT
$3.26M
– –
0
– –
LGF.A
5260
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$3K ﹤0.01%
589
-5,922
-91% -$41.8K
VINC
5261
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3K ﹤0.01%
133
+131
+6,550% +$2.47K
PRLH
5262
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$3K ﹤0.01%
270
+169
+167% +$1.71K
AKTS
5263
DELISTED
Akoustis Technologies Inc
AKTS
$3K ﹤0.01%
1,132
-4,115
-78% -$12.9K
LUXH
5264
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$3K ﹤0.01%
+29
New +$3.23K
FIACU
5265
DELISTED
Focus Impact Acquisition Corp. Unit
FIACU
$3K ﹤0.01%
248
– –
MMAT
5266
DELISTED
Meta Materials Inc. Common Stock
MMAT
$3K ﹤0.01%
22
-165
-88% -$21.8K
DYNT
5267
DELISTED
Dynatronics Corp
DYNT
$3K ﹤0.01%
1,494
-54
-3% -$122
DMTK
5268
DELISTED
DermTech, Inc. Common Stock
DMTK
$3K ﹤0.01%
1,704
-3,643
-68% -$9.69K
BIOL
5269
DELISTED
Biolase, Inc.
BIOL
$3K ﹤0.01%
53
+33
+165% +$4.75K
THMO
5270
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$3K ﹤0.01%
891
+860
+2,774% +$5.66K
AONC
5271
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$3K ﹤0.01%
327
-46
-12% -$457
OPGN
5272
DELISTED
OpGen, Inc
OPGN
$3K ﹤0.01%
90
-14
-13% -$515
NBSE
5273
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3K ﹤0.01%
888
+245
+38% +$1.26K
FEN
5274
DELISTED
First Trust Energy Income and Growth Fund
FEN
$3K ﹤0.01%
190
+90
+90% +$1.33K
PGSS
5275
DELISTED
Pegasus Digital Mobility Acquisition Corp.
PGSS
$3K ﹤0.01%
315
– –
209 210
211
212 213

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.